Home> Products> oral combination antidiabetic medicine

{ "products": [ { "_id": "6a8e88301c37b1652b78c6a7", "fptag": "ERNESTPHARMACEUTICAL", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Glimsmart MV Tablets", "description": "Glimsmart MV Tablets are triple-combination oral antidiabetic medicines used to help manage type 2 diabetes mellitus when treatment with multiple glucose-lowering mechanisms is considered appropriate.\n\nThe combination contains:\n\nGlimepiride – a sulfonylurea that stimulates insulin release from pancreatic beta cells.\nMetformin – a biguanide that primarily reduces glucose production by the liver and improves insulin sensitivity.\nVoglibose – an alpha-glucosidase inhibitor that delays carbohydrate digestion and absorption in the intestine, helping reduce post-meal blood glucose spikes.\n\nTogether, these three medicines provide complementary mechanisms for improving glycemic control alongside appropriate diet, exercise, and medical supervision.\n\nAvailable Variants\nProduct\tGlimepiride\tMetformin\tVoglibose\nGlimsmart MV 1.3\t1 mg\t500 mg\t0.3 mg\nGlimsmart MV 2.3\t2 mg\t500 mg\t0.3 mg\nGlimsmart MV 3.3\t3 mg\t500 mg\t0.3 mg\nDosage\n\nThe appropriate strength and dosage should be determined by a healthcare professional based on:\n\nBlood-glucose levels\nPrevious antidiabetic treatment\nDiet and meal pattern\nKidney and liver function\nRisk of hypoglycemia\nClinical response\n\nBecause voglibose acts on carbohydrate absorption, timing in relation to meals is important. Patients should follow the specific instructions provided with the product or by their physician.\n\nDo not change the strength, dose, or treatment schedule without medical advice.\n\nPrecautions\nRegularly monitor blood glucose as advised.\nInform the doctor about kidney or liver disorders.\nAvoid skipping meals because glimepiride can cause hypoglycemia.\nInform the physician about all other antidiabetic medicines being taken.\nPatients should know the symptoms of low blood sugar and how to respond to them.\nGastrointestinal symptoms may occur due to metformin and voglibose.\nExcessive alcohol consumption should be avoided, particularly because of the metformin component.\nPregnancy and breastfeeding require medical consultation.\nLong-term metformin therapy may be associated with reduced vitamin B12 levels in some patients.\nSide Effects\n\nPossible side effects include:\n\nHypoglycemia\nNausea\nDiarrhea\nAbdominal discomfort\nFlatulence\nAbdominal bloating\nLoss of appetite\nAltered taste\nHeadache\nDizziness\n\nSymptoms of hypoglycemia may include sweating, trembling, hunger, weakness, dizziness, confusion, or rapid heartbeat.\n\nWarning\n\nGlimsmart MV Tablets should be used only according to medical advice.\n\nGlimepiride can cause significant hypoglycemia, especially if meals are skipped, delayed, or inadequate.\n\nMetformin has a rare but serious risk of lactic acidosis, particularly in patients with significant kidney impairment or other predisposing conditions.\n\nBecause voglibose delays carbohydrate digestion, ordinary table sugar (sucrose) may not correct hypoglycemia as rapidly. Glucose/dextrose is generally preferred when treating low blood glucose in patients taking an alpha-glucosidase inhibitor.\n\nOther Specifications\nSpecification\tInformation\nProduct Name\tGlimsmart MV\nVariants\t1.3, 2.3 & 3.3\nActive Ingredients\tGlimepiride + Metformin + Voglibose\nDosage Form\tTablet\nDrug Category\tOral antidiabetic\nGlimepiride Class\tSulfonylurea\nMetformin Class\tBiguanide\nVoglibose Class\tAlpha-glucosidase inhibitor\nPrimary Use\tType 2 diabetes mellitus\nRoute\tOral\nPrescription Status\tPrescription medicine\nStorage\tFollow manufacturer's labeled conditions\nFAQ\n\n1. What are Glimsmart MV Tablets used for?\nThey are used to help manage type 2 diabetes mellitus when triple-combination oral therapy is considered appropriate.\n\n2. What does Glimsmart MV 1.3 contain?\nIt contains Glimepiride 1 mg + Metformin 500 mg + Voglibose 0.3 mg.\n\n3. What does Glimsmart MV 2.3 contain?\nIt contains Glimepiride 2 mg + Metformin 500 mg + Voglibose 0.3 mg.\n\n4. What does Glimsmart MV 3.3 contain?\nIt contains Glimepiride 3 mg + Metformin 500 mg + Voglibose 0.3 mg.\n\n5. What is the main difference between the three variants?\nThe Glimepiride strength changes from 1 mg to 2 mg to 3 mg, while Metformin remains 500 mg and Voglibose remains 0.3 mg.\n\n6. How does Voglibose help control blood sugar?\nVoglibose slows the digestion and absorption of carbohydrates in the intestine, helping reduce the rise in blood glucose after meals.\n\n7. Can Glimsmart MV cause low blood sugar?\nYes. Hypoglycemia can occur, primarily because of the glimepiride component, particularly when meals are missed or delayed.\n\n8. Can Glimsmart MV be used for type 1 diabetes?\nThis combination is intended for type 2 diabetes management and should not be considered a substitute for insulin in type 1 diabetes.", "price": 0.0, "discountamount": 0.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 245, "imageuri": "https://productimages.withfloats.com/actual/6a8e8833741c13bda8fe90ca.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a8e8833741c13bda8fe90ca.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-08-26T06:31:12.663Z", "updatedon": "2026-08-26T06:31:12.663Z", "buyonlinelink": null, "producturl": "https://WWW.ERNESTIMPEX.IN/products/glimsmart-mv-tablets/245", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Glimsmart MV", "category": "General Medicine", "tags": [ "Glimsmart MV 3.3 Tablets", "Glimsmart MV 2.3 Tablets", "Glimsmart MV 1.3 Tablets | Glimepiride 1 mg + Metformin 500 m" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "None", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a8e85bf593ab28cec3d91ee", "fptag": "ERNESTPHARMACEUTICAL", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Glimsmart M 501 & 502 Tablets", "description": "Generic Name: Glimepiride + Metformin Hydrochloride\n\nGlimsmart M 501 Tablet and Glimsmart M 502 Tablet are combination oral antidiabetic medicines containing Glimepiride and Metformin Hydrochloride. They are used to help manage type 2 diabetes mellitus when combination treatment is considered appropriate.\n\nGlimepiride belongs to the sulfonylurea class and lowers blood glucose mainly by stimulating insulin release from pancreatic beta cells. Metformin is a biguanide that mainly reduces hepatic glucose synthesis and enhances tissue insulin sensitivity.\n\nTogether, these medicines help improve blood-glucose control alongside an appropriate diet, physical activity, and other measures recommended by a healthcare professional.\n\nAvailable Variants\nProduct\tActive Ingredients\nGlimsmart M 501 Tablet\tGlimepiride + Metformin Hydrochloride\nGlimsmart M 502 Tablet\tGlimepiride + Metformin Hydrochloride\n\nNote: The product names alone do not reliably establish the exact milligram strength of each ingredient. The complete composition of the 501 and 502 variants should be confirmed from their respective product packs.\n\nDosage\n\nAnd the amount should be given by a healthcare professional per\nCurrent blood-glucose levels\nPrevious diabetes treatment\nKidney and liver function\nPatient's diet and lifestyle\nRisk of hypoglycemia\nClinical response to treatment\n\nGlimepiride/metformin combinations are generally taken with or immediately before a meal according to the specific product instructions. Skipping meals after taking a sulfonylurea can increase the risk of low blood sugar.\n\nPrecautions\nMonitor blood glucose regularly as recommended.\nDo not skip or substantially delay meals after taking the medicine.\nInform the physician about all other diabetes medicines being used.\nAlcohol may increase the risk of adverse effects and should be discussed with the healthcare professional.\nMetformin requires particular caution in conditions that increase the risk of lactic acidosis.\nPatients should know how to recognize and manage symptoms of hypoglycemia.\nPregnancy and breastfeeding require medical consultation.\nSide Effects\n\nPossible side effects include:\n\nHypoglycemia (low blood sugar)\nNausea\nDiarrhea\nAbdominal discomfort\nLoss of appetite\nHeadache\nDizziness\nAltered taste\n\nSymptoms of hypoglycemia can include sweating, trembling, hunger, dizziness, weakness, confusion, and rapid heartbeat.\n\nWarning\n\nGlimsmart M Tablets should be used under medical supervision.\n\nGlimepiride can cause potentially significant hypoglycemia, particularly when meals are missed, food intake is inadequate, or certain other glucose-lowering medicines are used.\n\nMetformin has a rare but serious risk of lactic acidosis, particularly in patients with significant renal impairment or other predisposing conditions.\n\nFAQ\n\n1. What are Glimsmart M 501 and M 502 Tablets used for?\nThey are combination medicines used to help control blood glucose in patients with type 2 diabetes mellitus when prescribed.\n\n2. What do Glimsmart M Tablets contain?\nThey contain Glimepiride and Metformin Hydrochloride.\n\n3. How does Glimepiride work?\nGlimepiride works by stimulating the beta cells in the pancreas to release insulin which helps to reduce blood glucose.\n\n4. How does Metformin work?\nMetformin mainly lowers hepatic glucose production and enhances insulin sensitivity.\n\n5. Can Glimsmart M cause low blood sugar?\nYes. The glimepiride component can cause hypoglycemia, particularly if meals are skipped or delayed.\n\n6. What is the difference between Glimsmart M 501 and M 502?\nThey represent different strength formulations of the glimepiride/metformin combination. The exact strength of each ingredient should be confirmed from the individual product label.", "price": 0.0, "discountamount": 0.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 244, "imageuri": "https://productimages.withfloats.com/actual/6a8e85c2f56378af34422689.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a8e85c2f56378af34422689.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-08-26T06:20:47.651Z", "updatedon": "2026-08-26T06:20:47.651Z", "buyonlinelink": null, "producturl": "https://WWW.ERNESTIMPEX.IN//glimsmart-m-501-502-tablets/244", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Glimsmart", "category": "General Medicine", "tags": [ "Buy Glimsmart M 501mg Tablets Online", "Glimsmart M 501 Tablets", "Buy Glimismart MF 2mg/500mg Tablet SR Online", "Glimsmart-M 502mg tablet, 1*10 Tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "None", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a8d618ed8739d508efaf041", "fptag": "ERNESTPHARMACEUTICAL", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Empafox Met tablet", "description": "Empafox 10, Empafox 25 & Empafox Met 12.5/500 Tablets\n\nEmpafox Tablets are oral antidiabetic medicines used in the management of type 2 diabetes mellitus.\n\nEmpafox 10 and Empafox 25 contain Empagliflozin, an SGLT2 (sodium-glucose cotransporter-2) inhibitor. Empagliflozin lowers blood glucose by reducing glucose reabsorption in the kidneys and increasing the amount of glucose eliminated through urine.\n\nEmpafox Met 12.5/500 combines Empagliflozin 12.5 mg with Metformin Hydrochloride 500 mg. Metformin primarily reduces glucose production by the liver and improves the body's response to insulin. The combination provides complementary mechanisms for improving glycemic control.\n\nAvailable Variants\nProduct\tComposition\nEmpafox 10 Tablets\tEmpagliflozin 10 mg\nEmpafox 25 Tablets\tEmpagliflozin 25 mg\nEmpafox Met 12.5/500 Tablets\tEmpagliflozin 12.5 mg + Metformin Hydrochloride 500 mg\nDosage\n\nThe appropriate dose should be determined by a healthcare professional according to:\n\nBlood-glucose control\nKidney function\nCurrent diabetes treatment\nPatient's overall medical condition\nResponse and tolerance to therapy\n\nEmpafox Met is generally taken with food to help reduce gastrointestinal side effects associated with metformin, subject to the specific formulation instructions.\n\nPatients should not increase, reduce, or discontinue their diabetes medication without medical advice.\n\nPrecautions\nKidney function should be evaluated before and during treatment when clinically appropriate.\nMaintain adequate hydration because empagliflozin can increase urination.\nInform the doctor about recurrent urinary or genital infections.\nTell the healthcare professional about kidney, liver, or heart conditions.\nInform the doctor about all other antidiabetic medicines being used.\nTemporary interruption may be necessary during serious illness, prolonged fasting, or around major surgery, according to medical advice.\nMetformin-containing products require assessment of factors that increase the risk of lactic acidosis.\nPregnancy and breastfeeding require medical consultation.\nSide Effects\n\nPossible effects associated with empagliflozin include:\n\nIncreased urination\nIncreased thirst\nGenital fungal infections\nUrinary tract infections\nDizziness or dehydration\n\nEmpafox Met may additionally cause:\n\nNausea\nDiarrhea\nAbdominal discomfort\nLoss of appetite\nAltered taste\n\nHypoglycemia is more likely when these medicines are combined with insulin or certain other glucose-lowering medicines.\n\nWarning\n\nEmpagliflozin has been associated with diabetic ketoacidosis, which may occasionally occur even without extremely high blood glucose. Symptoms such as nausea, vomiting, abdominal pain, unusual tiredness, or difficulty breathing require urgent medical evaluation.\n\nRare but serious infections involving the genital or perineal area have also been reported with SGLT2 inhibitors.\n\nFAQ\n\n1. What are Empafox Tablets used for?\nThey are used as part of the management of type 2 diabetes mellitus, along with appropriate diet, physical activity, and other treatment recommended by a healthcare professional.\n\n2. What is the difference between Empafox 10 and Empafox 25?\nThey contain different strengths of Empagliflozin: 10 mg and 25 mg, respectively.\n\n3. What does Empafox Met 12.5/500 contain?\nIt contains Empagliflozin 12.5 mg and Metformin Hydrochloride 500 mg.\n\n4. How does Empagliflozin work?\nIt blocks SGLT2 in the kidneys, reducing glucose reabsorption and increasing glucose elimination through urine.\n\n5. Why is Metformin combined with Empagliflozin?\nThe two medicines work through different mechanisms, providing complementary blood-glucose-lowering effects.\n\n6. Can Empafox cause low blood sugar?\nEmpagliflozin alone generally has a relatively low risk of hypoglycemia, but the risk can increase when combined with insulin or certain other antidiabetic medicines.\n\n7. Can Empafox cause urinary or genital infections?\nYes. Because SGLT2 inhibitors increase glucose in the urine, genital fungal infections and urinary tract infections can occur.\n\n8. Can patients with kidney problems use Empafox?\nKidney function is an important consideration, particularly for the Empafox Met formulation containing metformin. Treatment suitability should be assessed by a healthcare professional.", "price": 0.0, "discountamount": 0.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 223, "imageuri": "https://productimages.withfloats.com/actual/6a8d6190170beab740561a33.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a8d6190170beab740561a33.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-08-25T09:34:06.582Z", "updatedon": "2026-08-25T09:34:06.582Z", "buyonlinelink": null, "producturl": "https://WWW.ERNESTIMPEX.IN//empafox-met-tablet/223", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Empafox / Empafox Met", "category": "General Medicine", "tags": [ "Empagliflozin 25 mg", "Empagliflozin Metformin Tablets", "Empafox Met 12.5/500 Tab", "Empafox Met 12.5/500 Tab" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "None", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a8c23c7ac2b40bc6a94ddbc", "fptag": "ERNESTPHARMACEUTICAL", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Buy Dapafox Trio Tablets", "description": "Guide for the Dapafox Trio 500 and 1000 Tablets\n\nDapafox trio tablets are a triple combination of oral antidiabetic agents Dapagliflozin 10 mg + Sitagliptin 100 mg + Metformin Hydrochloride.\n\nThe two variations are\n\nDapafox Trio 500 Dapagliflozin 10mg + Sitagliptin 100mg + Metformin Hydrochloride 500mg\nDapafox Trio 1000: Dapagliflozin 10 mg + Sitagliptin 100 mg + Metformin Hydrochloride 1000 mg\n\nThis combination is used in the management of type 2 diabetes mellitus when combination therapy is deemed appropriate. The three components reduce blood glucose via complimentary methods.\n\nDapagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor that enhances urine glucose excretion Sitagliptin is a DPP-4 inhibitor that increases incretin activity, leading to glucose-dependent release of insulin and decreased glucagon secretion. Metformin is a biguanide that reduces hepatic glucose synthesis and increases insulin sensitivity.\n\nDrug Formulation\n\nOnly take Dapafox Trio as prescribed by a healthcare expert. The right treatment strength and schedule depends on:\n\nCurrent glycaemic control\nOther diabetic drugs previously\nRenal Function\nTolerability\nOther medical problems\n\nThis formulation contains metformin, and taking it with food may lessen gastrointestinal adverse effects. Take the tablets as indicated on the package label.\n\nSafety measures\nEvaluate renal function prior to therapy initiation and regularly as indicated.\nTell the doctor if you have ever had kidney, liver, heart or pancreatic issues.\nDapagliflozin increases urine glucose and fluid loss . Ensure appropriate hydrated.\nTell the doctor about recurring infections of the genital or urinary tract.\nPatients should let their doctor know all other diabetes medicines they are taking.\nMedical advise may be that treatment should be halted for a time surrounding major surgery, prolonged fasting, or very acute illness.\nMedical advice necessary in pregnancy and lactation.\nAlcohol should be avoided in excess, especially because of the metformin component.\nUnwanted Effects\n\nPossible side effects are:\n\nNausea\nDiarrhoea\nUpset stomach\nIncreased urination.\nExcessive thirst\nFungal infections of the genitals\nBladder infections\nHead-ache;\nLight-headedness\nLoss of appetite.\n\nHypoglycemia may occur when taken in combination with insulin or other glucose-lowering drugs.\n\nCaution\n\nDapagliflozin has been related with diabetic ketoacidosis, even cases where blood glucose is not markedly increased. Get medical help right away if you have nausea and vomiting that continue, stomach discomfort, unusual exhaustion, or trouble breathing.\n\nLactic acidosis is an uncommon but serious complication that can occur in people using metformin, especially in those with significant renal impairment or other contributing factors.\n\nFAQ\n\n1. What is the function of Dapafox Trio?\nThis medicine is a triple combination medicine that helps to control type 2 diabetes mellitus when this combination is regarded appropriate by a health care practitioner.\n\n2. What is Dapafox Trio 500 made of?\nIt comprises Dapagliflozin 10 mg + Sitagliptin 100 mg + Metformin Hydrochloride 500 mg.\n\n3. What is in Dapafox Trio 1000?\nEach film-coated tablet includes Dapagliflozin 10 mg + Sitagliptin 100 mg + Metformin Hydrochloride 1000 mg.\n\n4. What is the difference between Dapafox Trio 500 and Dapafox Trio 1000?\nThe difference is the strength of the Metformin. Dapafox Trio 500 includes 500 mg and Dapafox Trio 1000 has 1000 mg of Metformin Hydrochloride.\n\n5. How does Dapafox Trio regulate blood sugar?\nThe three ingredients function through separate mechanisms: dapagliflozin promotes urinary glucose excretion, sitagliptin helps with glucose-dependent insulin control, and metformin inhibits hepatic glucose synthesis and raises insulin sensitivity.\n\n6. Can Dapafox Trio lower blood sugar?\nThe risk of hypoglycaemia may be increased when used in combination with insulin or some other antidiabetic drugs.\n\n7. Dapafox Trio for type 1 diabetes?\nIt should not be considered acceptable for type 1 diabetes. Treatment must be in accordance with recognised indications and the advice of a specialist in diabetes.\n\n8. Is Dapafox Trio safe for persons with kidney problems?\nThe formulation combines dapagliflozin, sitagliptin and metformin, and kidney function is particularly crucial. Medical review for suitability and dose is required.", "price": 0.0, "discountamount": 0.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 188, "imageuri": "https://productimages.withfloats.com/actual/6a8c23c91d69f04f3addf78d.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a8c23c91d69f04f3addf78d.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-08-24T10:58:15.67Z", "updatedon": "2026-08-24T10:58:15.67Z", "buyonlinelink": null, "producturl": "https://WWW.ERNESTIMPEX.IN//buy-dapafox-trio-tablets/188", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Dapafox Trio", "category": "General Medicine", "tags": [ "Dapafox Trio Tablets", "Dapafox Trio 500", "Dapafox Trio 1000", "Dapafox Trio 1000 Tablets, 1000mg", "Dapafox Trio 500 Tablet" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "None", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a97f707e50c1c044989fa4d", "fptag": "ERNESTPHARMACEUTICAL", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Acebrophylline, Desloratadine & Montelukast", "description": "Montaheal 3D Tablet\n\nComposition: Acebrophylline 200 mg (SR) + Desloratadine 5 mg + Montelukast 10 mg\nDosage Form: Tablet\nTherapeutic Segment: Respiratory / Anti-allergic Medicine\n\nThree-Way Respiratory Formula\n\nMontaheal 3D combines three medicines that address different components of respiratory and allergic symptoms. It brings together a bronchodilator/mucoregulator, antihistamine, and leukotriene receptor antagonist in one formulation.\n\nThe 3 Components\n\nAcebrophylline 200 mg SR\nHelps improve airway function and has bronchodilator and mucus-regulating properties. The SR formulation is designed for sustained release.\n\nDesloratadine 5 mg\nA second-generation H1 antihistamine that reduces histamine-mediated allergic symptoms such as sneezing, itching, and nasal discharge.\n\nMontelukast 10 mg\nBlocks cysteinyl leukotriene receptors, helping reduce leukotriene-mediated airway and allergic inflammation.\n\nWhere This Combination Fits\n\nDepending on the approved product labeling and patient's condition, this combination may be considered where airway symptoms and an allergic component coexist, such as selected respiratory conditions associated with bronchospasm, mucus, or allergic symptoms.\n\nIt is not intended to replace a rapid-acting rescue medicine during an acute asthma attack.\n\n3D Action Map\nIngredient\tMain Therapeutic Contribution\nAcebrophylline SR\tAirway relaxation + mucus regulation\nDesloratadine\tHistamine/allergy control\nMontelukast\tLeukotriene pathway blockade\nSymptoms & Effects to Watch\n\nPossible adverse effects can include:\n\nHeadache\nNausea or stomach discomfort\nDizziness\nDry mouth\nPalpitations\nSleep-related or gastrointestinal disturbances\n\nQuestions\n\nWhy does Montaheal 3D contain three ingredients?\nEach component works through a different pathway, providing airway, mucus, and allergy-related therapeutic actions.\n\nWhat does SR mean with Acebrophylline?\nSR means sustained release, designed to release the medicine gradually according to the formulation.\n\nIs Desloratadine an antihistamine?\nYes. It is a second-generation H1 antihistamine used for allergic symptoms.\n\nIs Montaheal 3D a rescue tablet for sudden asthma attacks?\nNo. It should not be relied upon for immediate relief of an acute bronchospasm or asthma attack.\n\nWhy are mood or behavioral changes important?\nMontelukast carries an important warning regarding possible neuropsychiatric effects, so significant changes in mood, behavior, or sleep require medical attention.\n", "price": 0.0, "discountamount": 0.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 448, "imageuri": "https://productimages.withfloats.com/actual/6a97f7090b2581a823d691e9.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a97f7090b2581a823d691e9.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-09-02T10:14:31.371Z", "updatedon": "2026-09-02T10:14:31.371Z", "buyonlinelink": null, "producturl": "https://WWW.ERNESTIMPEX.IN//acebrophylline-desloratadine-montelukast/448", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Montaheal 3D", "category": "cardiac", "tags": [ "Buy Montaheal 3D Tablet SR Online", "Montaheal 3D Acebrophylline Desloratadine Montelukast", "Montaheal 3D Tablet" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "None", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a97f2cdf038ff4fdbea6a70", "fptag": "ERNESTPHARMACEUTICAL", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Bisoprolol Fumarate & Telmisartan", "description": "Bisocor T-2.5/40 Tablet is a prescription combination antihypertensive medicine containing Bisoprolol Fumarate 2.5 mg and Telmisartan 40 mg. It combines two cardiovascular medicines with different mechanisms of action to support the management of high blood pressure (hypertension) when combination therapy is considered appropriate by a healthcare professional.\n\nBisoprolol primarily helps reduce heart rate and cardiac workload, while Telmisartan helps relax blood vessels by blocking the effects of angiotensin II.\n\nHow Does Bisocor T-2.5/40 Work?\n\nBisoprolol Fumarate is a selective beta-1 blocker. It reduces the effects of adrenergic stimulation on the heart, helping slow the heart rate and decrease cardiac workload.\n\nTelmisartan belongs to the Angiotensin II Receptor Blocker (ARB) class. It blocks angiotensin II at AT1 receptors, helping prevent excessive narrowing of blood vessels.\n\nTogether, these actions help reduce vascular resistance and cardiac workload, supporting better blood pressure management.\n\nPrimary Use – Hypertension Management\n\nBisocor T-2.5/40 may be prescribed for patients who require a combination of Bisoprolol and Telmisartan for blood pressure control.\n\nLong-term management of hypertension is important because persistently elevated blood pressure can increase strain on the heart, blood vessels, kidneys, and other organs.\n\nKey Benefits & Features\n\nContains Bisoprolol Fumarate 2.5 mg + Telmisartan 40 mg\nFixed-dose cardiovascular combination\nCombines Beta-1 Blocker + ARB\nHelps control elevated blood pressure\nHelps reduce cardiac workload\nSupports relaxation of blood vessels\nProvides two complementary antihypertensive mechanisms\nConvenient oral combination tablet\n\nHow to Use\n\nTake Bisocor T-2.5/40 exactly according to the dose and treatment schedule prescribed by your healthcare professional.\n\nSwallow the tablet with water and follow a consistent treatment routine. Do not suddenly discontinue a Bisoprolol-containing medicine without medical advice.\n\nPossible Side Effects\n\nPossible side effects may include:\n\nDizziness\nTiredness or weakness\nHeadache\nSlow heart rate\nLow blood pressure\nNausea\nCold hands or feet\nChanges in potassium levels\n\nImportant Precautions\n\nBefore using Bisocor T-2.5/40, inform your doctor if you have:\n\nVery slow heart rate\nLow blood pressure\nHeart conduction problems\nHeart failure\nKidney or liver impairment\nAsthma or other respiratory conditions\nDiabetes\nElectrolyte abnormalities\n\nCommon Queries\n\nWhy are Bisoprolol and Telmisartan combined?\nThey lower blood pressure through different mechanisms, allowing complementary antihypertensive action when combination treatment is appropriate.\n\nCan Bisocor T reduce heart rate?\nYes. Bisoprolol can reduce heart rate through beta-1 receptor blockade.\n\nCan this medicine increase potassium?\nTelmisartan can cause hyperkalemia, particularly in susceptible patients or with certain interacting medicines.\n\nCan treatment be stopped suddenly?\nBisoprolol-containing treatment should not generally be discontinued abruptly without medical advice because sudden withdrawal can worsen cardiovascular symptoms.", "price": 0.0, "discountamount": 0.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 444, "imageuri": "https://productimages.withfloats.com/actual/6a97f2d0522a763707935b53.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a97f2d0522a763707935b53.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-09-02T09:56:29.756Z", "updatedon": "2026-09-02T09:56:29.756Z", "buyonlinelink": null, "producturl": "https://WWW.ERNESTIMPEX.IN//bisoprolol-fumarate-telmisartan/444", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Bisocor T", "category": "cardiac", "tags": [ "Buy Bisocor T 2.5/40 Tablet Online: View Uses, Side", "Bisocor t 2.5-40", "Bisoprolol Telmisartan Tablets", "Bisoprolol Fumarate 2.5mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "None", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a9673ba8177c0b2ccae037f", "fptag": "ERNESTPHARMACEUTICAL", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Bemcardia EZ 180/10 Tablet", "description": "Bemcardia EZ 180/10 Tablet is a prescription lipid-lowering combination medicine containing Bempedoic Acid 180 mg and Ezetimibe 10 mg. It is used for the management of high cholesterol, particularly elevated LDL cholesterol, when a healthcare professional considers this combination appropriate.\n\nThe medicine combines two cholesterol-lowering mechanisms in one tablet. Bempedoic Acid reduces cholesterol synthesis in the liver, while Ezetimibe reduces cholesterol absorption from the small intestine.\n\nHow Does Bemcardia EZ 180/10 Work?\n\nBempedoic Acid inhibits an enzyme known as ATP citrate lyase (ACL), which is involved in cholesterol production in the liver. This action helps reduce the amount of cholesterol produced by the body.\n\nEzetimibe acts in the small intestine and reduces the absorption of cholesterol.\n\nBy targeting both cholesterol production and intestinal cholesterol absorption, the combination helps lower cholesterol levels through two complementary pathways.\n\nPrimary Use – Management of High Cholesterol\n\nBemcardia EZ 180/10 is prescribed for the treatment of high cholesterol. Cholesterol management is generally combined with appropriate diet, exercise and other lifestyle measures recommended by a healthcare professional.\n\nKey Features\nContains Bempedoic Acid 180 mg + Ezetimibe 10 mg\nDual-action lipid-lowering formulation\nHelps reduce cholesterol synthesis in the liver\nHelps decrease intestinal cholesterol absorption\nUsed for management of high cholesterol\nFixed-dose oral combination tablet\nPrescription medicine for physician-directed treatment\nHow to Use\n\nTake Bemcardia EZ 180/10 in the dose and duration prescribed by your doctor. The tablet should be swallowed whole and should not be crushed, chewed or broken. It may be taken with or without food.\n\nPossible Side Effects\n\nPossible side effects may include increased uric acid, abdominal discomfort, diarrhea, back or joint pain, fatigue, muscle spasms, increased liver enzymes and respiratory tract symptoms.\n\nContact your healthcare professional if side effects persist, worsen or become concerning.\n\nImportant Precautions\n\nBefore starting treatment, tell your doctor about your existing medical conditions and all medicines or supplements you are taking. Bempedoic acid may increase uric acid levels, while liver function may require monitoring in some patients. Unexplained muscle pain, tenderness or weakness should also be reported to a healthcare professional.", "price": 0.0, "discountamount": 0.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 397, "imageuri": "https://productimages.withfloats.com/actual/6a9673bc155eb2dff49f9495.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a9673bc155eb2dff49f9495.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-09-01T06:42:02.236Z", "updatedon": "2026-09-01T06:42:02.236Z", "buyonlinelink": null, "producturl": "https://WWW.ERNESTIMPEX.IN//bemcardia-ez-180-10-tablet/397", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Bemcardia", "category": "cardiac", "tags": [ "Bempedoic Acid Ezetimibe Supplier India", "Bemcardia EZ 180/10", "Bemcardia EZ Tablet", "Lipid Lowering Tablet" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "None", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a9671bfed078617ad2e78db", "fptag": "ERNESTPHARMACEUTICAL", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Bisocor Dapa 2.5/10 Tablet", "description": "Bisocor Dapa 2.5/10 Tablet is a prescription combination medicine containing Bisoprolol Fumarate 2.5 mg and Dapagliflozin 10 mg. The product is marketed by Healing Pharma and combines a beta-blocker with an SGLT2 inhibitor in a single oral tablet.\n\nThis combination brings together two medicines with different pharmacological actions. Bisoprolol primarily acts on beta-1 receptors in the heart, helping reduce heart rate and cardiac workload. Dapagliflozin works in the kidneys by inhibiting sodium-glucose cotransporter-2 (SGLT2), increasing urinary glucose excretion.\n\nHow Does Bisocor Dapa 2.5/10 Work?\n\nBisoprolol is a selective beta-1 adrenergic blocker. It reduces the effects of certain stress hormones on the heart, which can help lower heart rate and reduce cardiac workload.\n\nDapagliflozin is an SGLT2 inhibitor. It reduces glucose reabsorption in the kidneys, allowing excess glucose to be eliminated through urine.\n\nThe combination should be used only for patients for whom both components are considered appropriate by a healthcare professional.\n\nKey Features\nContains Bisoprolol 2.5 mg + Dapagliflozin 10 mg\nCombines Beta-1 Blocker + SGLT2 Inhibitor\nFixed-dose oral combination\nPrescription-only medicine\nBisoprolol supports cardiovascular management\nDapagliflozin provides SGLT2 inhibition\nAvailable as a tablet formulation\nHealing Pharma product\nHow to Use\n\nBisocor Dapa 2.5/10 should be taken exactly according to the dose and duration prescribed by a healthcare professional. Swallow the tablet with water and follow the recommended treatment schedule.\n\nDo not stop a Bisoprolol-containing medicine suddenly unless instructed by your doctor.\n\nPossible Side Effects\n\nDepending on the individual patient, effects associated with its active ingredients can include:\n\nDizziness or weakness\nSlow heart rate\nLow blood pressure\nIncreased urination\nGenital fungal infections\nUrinary tract infections\nDehydration or increased thirst\nChanges in blood glucose\n\nSeek medical advice if symptoms are persistent, severe or unusual.\n\nImportant Precautions\n\nBefore using Bisocor Dapa 2.5/10, tell your healthcare professional if you have kidney problems, low blood pressure, dehydration, diabetes, heart rhythm problems, a very slow heart rate, asthma or other respiratory disorders.\n\nPatients taking this combination may require monitoring based on their underlying medical condition and concurrent medicines. It should not be used for self-medication.", "price": 0.0, "discountamount": 0.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 394, "imageuri": "https://productimages.withfloats.com/actual/6a9671c15b576c132f0ab907.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a9671c15b576c132f0ab907.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-09-01T06:33:35.37Z", "updatedon": "2026-09-01T06:33:35.37Z", "buyonlinelink": null, "producturl": "https://WWW.ERNESTIMPEX.IN//bisocor-dapa-2-5-10-tablet/394", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Bisocor", "category": "cardiac", "tags": [ "Bisocor Dapa 2.5/10", "Bisocor Dapa Tablet", "Bisoprolol Dapagliflozin Supplier", "Dapagliflozin Tablets Supplier India" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "None", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a95782e2d55612fe259041d", "fptag": "ERNESTPHARMACEUTICAL", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Buy Telmaheal LNB 25", "description": "Telmaheal LNB 25 Tablet is a prescription triple-combination antihypertensive medicine formulated with Telmisartan, Cilnidipine and Metoprolol Succinate (Extended Release). It is designed for the management of high blood pressure (hypertension) in patients who require multiple mechanisms of blood pressure control under medical supervision.\n\nUnlike standard single-drug therapy, Telmaheal LNB 25 combines an Angiotensin II Receptor Blocker (ARB), a calcium channel blocker (CCB), and a beta-blocker in one oral formulation. This multi-mechanism approach helps manage vascular resistance, blood vessel relaxation and cardiac workload.\n\nHow Does Telmaheal LNB 25 Work?\n\nTelmisartan blocks the effects of angiotensin II, helping prevent excessive narrowing of blood vessels and supporting smoother blood flow.\n\nCilnidipine is a calcium channel blocker that helps relax blood vessels, thereby reducing resistance against which the heart has to pump.\n\nMetoprolol Succinate ER is a beta-blocker with extended-release action. It helps reduce excessive heart rate and cardiac workload.\n\nTogether, these three components provide a multi-pathway approach to hypertension management.\n\nPrimary Use – Management of Hypertension\n\nTelmaheal LNB 25 may be prescribed when a healthcare professional determines that a combination of different antihypertensive drug classes is required to manage elevated blood pressure.\n\nConsistent blood pressure management is important for reducing prolonged stress on the heart, blood vessels, kidneys and other vital organs.\n\nKey Features\nTriple-action antihypertensive formulation\nContains Telmisartan + Cilnidipine + Metoprolol Succinate ER\nCombines ARB + CCB + Beta-Blocker\nSupports effective blood pressure management\nHelps relax and widen blood vessels\nHelps reduce cardiac workload\nExtended-release Metoprolol component\nConvenient fixed-dose oral combination\nHow to Use\n\nTake Telmaheal LNB 25 exactly according to the dose and duration prescribed by your doctor. Swallow the tablet whole with water. Since the formulation contains an extended-release component, the tablet should not be crushed or chewed unless specifically advised by a healthcare professional.\n\nDo not suddenly stop taking a Metoprolol-containing medicine without medical advice.\n\nPossible Side Effects\n\nSome patients may experience:\n\nDizziness\nHeadache\nTiredness or weakness\nSlow heart rate\nLow blood pressure\nSwelling of the ankles or feet\nNausea\nLight-headedness\n\nSeek medical advice if these effects become persistent or severe.", "price": 0.0, "discountamount": 0.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 385, "imageuri": "https://productimages.withfloats.com/actual/6a965fbe5b576c132f0ab6dc.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/6a965fbe5b576c132f0ab6dc.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-08-31T12:48:46.946Z", "updatedon": "2026-09-01T05:16:45.307Z", "buyonlinelink": null, "producturl": "https://WWW.ERNESTIMPEX.IN//buy-telmaheal-lnb-25/385", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Telmaheal", "category": "cardiac", "tags": [ "Telmaheal LNB 25", "Telmaheal LNB 25 Tablet", "Telmisartan Cilnidipine Metoprolol Supplier India", "Telmaheal LNB 25 Supplier" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "None", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }